| SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer (NCT01075308) | NCIC Clinical Trials Group | 2010-06-28 |
| High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB) (NCT02177292) | Medical College of Wisconsin | 2010-06-23 |
| Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T (NCT01174368) | The Rogosin Institute | 2010-06-01 |
| Dutasteride in Treating Patients With Prostate Cancer (NCT01193855) | University College London Hospitals | 2010-06-01 |
| Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach (NCT01138527) | Radboud University Medical Center | 2010-06-01 |
| Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancer (NCT01188408) | INSYS Therapeutics Inc | 2010-06-01 |
| Early Start of Oral Sildenafil 100mg for Erectile Dysfunction After Robotic Assisted Laparoscopic Radical Prostatectomy (NCT01054001) | Seoul National University Bundang Hospital | 2010-06-01 |
| Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC) (NCT01140373) | Memorial Sloan Kettering Cancer Center | 2010-06-01 |
| Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery (NCT01079793) | University of Texas Southwestern Medical Center | 2010-05-26 |
| Safety and Efficacy Study of TAK-700 in Patients With Nonmetastatic Castration-resistant Prostate Cancer and a Rising Prostate-specific Antigen (NCT01046916) | Millennium Pharmaceuticals, Inc. | 2010-05-01 |
| Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA) (NCT01118741) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2010-05-01 |
| Response of Patients on Surveillance for Prostate Cancer to Dutasteride (NCT01525914) | Sunnybrook Health Sciences Centre | 2010-05-01 |
| Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate Cancer (NCT01146340) | Sunnybrook Health Sciences Centre | 2010-05-01 |
| Anatomical and Functional Differences Between Continent and Incontinent Men Post Radical Prostatectomy (NCT01832831) | University of Michigan | 2010-05-01 |
| Cost Efficacy Evaluation of Robot Assisted Radical Prostatectomy (NCT02784314) | Hospices Civils de Lyon | 2010-05-01 |
| PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy (NCT01144897) | Daniel Vaena | 2010-05-01 |
| Korean Practice Patterns for Screening PCA(Prostate Cancer) (NCT01371513) | GlaxoSmithKline | 2010-05-01 |
| Guided Biopsy for Mapping Prostate Cancer (NCT01007214) | Roswell Park Cancer Institute | 2010-05-01 |
| Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer (NCT01132599) | Cancer Research UK | 2010-05-01 |
| TKI258 in Castrate Resistant Prostate Cancer (NCT00831792) | M.D. Anderson Cancer Center | 2010-04-07 |
| ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate Cancer (NCT01119118) | University of Wisconsin, Madison | 2010-04-01 |
| Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy (NCT01961713) | Massachusetts General Hospital | 2010-04-01 |
| Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate Brachytherapy (NCT01379742) | Prostate Cancer Foundation of Chicago | 2010-04-01 |
| A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate Cancer (NCT01085422) | AbbVie (prior sponsor, Abbott) | 2010-04-01 |
| Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer (NCT01155791) | Sandy Srinivas | 2010-04-01 |
| The Value of MultiSpectral 3 Tesla MRI in Active Surveillance of Prostate Cancer (NCT01896713) | Sunnybrook Health Sciences Centre | 2010-04-01 |
| Effect of Guided Imagery and Progressive Muscle Relaxation as a Means to Improve the Psychological Well-being and the Quality of Life for Patients With Breast and Prostate Cancer (NCT01275872) | Cyprus University of Technology | 2010-04-01 |
| Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor (NCT01459653) | Sandoz | 2010-03-01 |
| Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer (NCT01071915) | Ferring Pharmaceuticals | 2010-03-01 |
| Semen Analysis After Proton Therapy for Prostate Cancer (NCT01072513) | University of Florida | 2010-03-01 |
| Daily Target Guided Radiation Therapy Using the Calypso 4D Localization System in Patients Who Have Had a Prostatectomy for Prostate Cancer (NCT01624623) | U.S. Army Medical Research Acquisition Activity | 2010-03-01 |
| A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer (NCT01084759) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2010-03-01 |
| A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC) (NCT01090765) | National Cancer Institute (NCI) | 2010-02-23 |
| Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer (NCT00574769) | University of Southern California | 2010-02-17 |
| Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up (NCT01098552) | Mayo Clinic | 2010-02-01 |
| Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator (NCT00999960) | Assistance Publique - Hôpitaux de Paris | 2010-02-01 |
| Micro-RNA Expression Profiles in Localised Prostate Cancer (NCT03338712) | Wuerzburg University Hospital | 2010-02-01 |
| Detection of Micrometastases in Lymph Nodes of Patients With Prostate Cancer (NCT01615965) | Technical University of Munich | 2010-02-01 |
| Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer (NCT01050842) | Mayo Clinic | 2010-02-01 |
| Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel (NCT01051570) | Barbara Ann Karmanos Cancer Institute | 2010-02-01 |
| S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin (NCT01120262) | SWOG Cancer Research Network | 2010-02-01 |
| Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer (NCT01059513) | Jonsson Comprehensive Cancer Center | 2010-01-26 |
| Vitamin D Supplementation in Veterans With Early-Stage Prostate Cancer (NCT00953225) | VA Office of Research and Development | 2010-01-07 |
| Exercising Together: An Intervention for Prostate Cancer Survivors and Spouses (NCT00954044) | Oregon Health and Science University | 2010-01-01 |
| Modeling Clinical Failure in Prostate Cancer Patients Based on a Two-stage Statistical Model (NCT03979079) | Institut Bergonié | 2010-01-01 |
| Study of POMELLA™ Extract to Treat Prostate Cancer (NCT01100866) | Vancouver Coastal Health | 2010-01-01 |
| SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience (NCT03604211) | Kantonsspital Graubuenden | 2010-01-01 |
| Pilot Study of a Catheter-based Ultrasound Hyperthermia System (NCT00911079) | University of California, San Francisco | 2009-12-18 |
| Ketoconazole and Dexamethasone in Prostate Cancer (NCT01036594) | University of California, San Francisco | 2009-12-11 |
| Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, Effectiveness (NCT01036321) | H. Lee Moffitt Cancer Center and Research Institute | 2009-12-11 |
| External Immobilization Compared to Limited Immobilization Using a Novel Real-time Localization System of the Prostate (NCT01588938) | U.S. Army Medical Research Acquisition Activity | 2009-12-01 |
| A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate Biopsy (NCT01748890) | Massachusetts General Hospital | 2009-12-01 |
| The Long Term Effect of MRI Before Radical Prostatectomy. (NCT06429878) | Oslo University Hospital | 2009-12-01 |
| Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer (NCT01088529) | Cougar Biotechnology, Inc. | 2009-12-01 |
| Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer (NCT01040624) | University of Florida | 2009-12-01 |
| Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss (NCT00925600) | Amgen | 2009-11-30 |
| Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer (NCT00988208) | Celgene | 2009-11-11 |
| Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer (NCT00941915) | Duke University | 2009-11-09 |
| Phase II Study to Evaluate Conventional Radiation Therapy Followed by Radiosurgical Boost in Clinically Localized Prostate Cancer (NCT01618851) | Georgetown University | 2009-11-01 |
| Preoperative Magnetic Resonance (MR) Imaging of Prostate Cancer (NCT01347320) | Oslo University Hospital | 2009-11-01 |
| Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling (NCT00937833) | Cook Group Incorporated | 2009-11-01 |
| Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer (NCT01020448) | Ipsen | 2009-11-01 |
| Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2 (NCT01160705) | Cancer Trials Ireland | 2009-11-01 |
| A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer (NCT00924469) | Janssen Research & Development, LLC | 2009-11-01 |
| An Alternative to A Fixed Schedule In Management Of Prostate Cancer (NCT01056562) | University Health Network, Toronto | 2009-11-01 |
| MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer (NCT01094665) | University Health Network, Toronto | 2009-11-01 |
| Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers (NCT00984919) | Barbara Ann Karmanos Cancer Institute | 2009-11-01 |
| Feasibility of Using SPECT/CT Imaging to Map Lymphatic Drainage Patterns in Prostate Cancer Patients (NCT01008969) | University of California, San Francisco | 2009-11-01 |
| PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients (NCT01020604) | AstraZeneca | 2009-11-01 |
| Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy (NCT00931528) | Radiation Therapy Oncology Group | 2009-11-01 |
| A Safety Study of ZD4054 in Prior Chemotherapy Treated Patients With Metastatic Hormone-resistant Prostate Cancer (NCT01000948) | Aarhus University Hospital | 2009-10-01 |
| Functional Outcomes and QoL in Patients With High Versus Low and Intermediate Risk Prostate Cancer Treated by RARP (NCT03790995) | KU Leuven | 2009-10-01 |
| Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer (NCT00901342) | Dendreon | 2009-10-01 |
| The BIOPRES Trial: Transrectal BIOpsies of the PRostate: End Versus Side-firing (NCT00851292) | Amphia Hospital | 2009-10-01 |
| Post-operative or Early Salvage XRT and ADT for High Risk PCa (NCT00949962) | European Organisation for Research and Treatment of Cancer - EORTC | 2009-10-01 |
| Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer (NCT01020305) | Sandy Srinivas | 2009-10-01 |
| ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer (NCT00959959) | LTN PHARMACEUTICALS, INC. | 2009-10-01 |
| A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer (NCT00992745) | Molecular Insight Pharmaceuticals, Inc. | 2009-10-01 |
| Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer (NCT00953576) | Dana-Farber Cancer Institute | 2009-09-29 |
| A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With Cancer (NCT00984321) | Memorial Sloan Kettering Cancer Center | 2009-09-22 |
| Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer (NCT00976755) | Swiss Cancer Institute | 2009-09-14 |
| Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer (NCT00922129) | St. Joseph's Healthcare Hamilton | 2009-09-01 |
| Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis (NCT00918645) | University of California, Davis | 2009-09-01 |
| MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy (NCT00963300) | University of Texas Southwestern Medical Center | 2009-09-01 |
| Prostate Cancer Antigen 3 (PCA-3) Gene Project (NCT01177436) | Assistance Publique Hopitaux De Marseille | 2009-09-01 |
| Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer (NCT00985738) | University of Colorado, Denver | 2009-09-01 |
| The Effect of Endurance Training on Body Composition and Insulin Sensitivity in Prostate Cancer Patients Receiving Androgen Deprivation Therapy (NCT01676480) | Inge Holm | 2009-09-01 |
| Study Using WST11 in Patients With Localized Prostate Cancer (NCT00975429) | Steba Biotech S.A. | 2009-09-01 |
| Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer (NCT00970203) | Roswell Park Cancer Institute | 2009-09-01 |
| A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate Cancer (NCT00992186) | Centocor Research & Development, Inc. | 2009-09-01 |
| FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer (NCT01168479) | UMC Utrecht | 2009-09-01 |
| Investigative Study of the Role of Focal Therapy for Prostate Cancer Treatment (NCT00928603) | Università Vita-Salute San Raffaele | 2009-09-01 |
| Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer (NCT00936390) | Radiation Therapy Oncology Group | 2009-09-01 |
| F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer (NCT00963755) | University of Lausanne Hospitals | 2009-08-01 |
| Periperal Blood Lymphocytes During Prostate RT (NCT01899391) | University Health Network, Toronto | 2009-08-01 |
| A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function (NCT02001571) | Cougar Biotechnology, Inc. | 2009-08-01 |
| Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy (NCT00969111) | Proton Collaborative Group | 2009-08-01 |
| Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer (NCT00953277) | Axogen Corporation | 2009-08-01 |
| Androcur Non-interventional Study Among Patients With Carcinoma of the Prostate (NCT00919022) | Bayer | 2009-08-01 |
| Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients (NCT00884273) | Ferring Pharmaceuticals | 2009-08-01 |